Julia Oxford

Prof. Julia Oxford

Department of Biological Sciences, Boise State University, Boise, ID 83725, USA
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1995 in Cell
Verified
Journal Article
Closed access
YLY Li
Y Li
DLD.A Lacerda
D.A Lacerda
MWM.L Warman
M.L Warman
DBD.R Beier
D.R Beier
HYH Yoshioka
H Yoshioka
BOB.R Olsen
B.R Olsen

1 February 2003 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
DFDavid D. Frisbie
David D. Frisbie
Julia OxfordJulia Oxford
Julia Oxford
LSLouise Southwood
Louise Southwood
GTGayle W. Trotter
Gayle W. Trotter
WRWilliam G. Rodkey
William G. Rodkey
CMC. Wayne McIlwraith
C. Wayne McIlwraith
The current study investigated healing of large full-thickness articular cartilage defects during the first 8 weeks with and without penetration of the subchondral bone using microfracture in an established equine model of cartilage healing. Chondral defects in the weightbearing portion of the medial femoral condyle were made bilaterally; one defect in each horse was microfractured whereas the contralateral leg served as the control. The expression of cartilage extracellular matrix components (Types I and II collagen and aggrecan) was evaluated using histologic techniques, reverse transcription coupled polymerase chain reaction, in situ hybridization, and immunohistochemistry. This study confirms an increase in Type II collagen mRNA expression in repair tissue as early as 6 weeks after microfracture. Although other matrix mRNA and protein levels changed in concentration and tissue location over the course of the study, no significant differences were seen in microfractured defects. Although the microfracture techniques appear to improve clinical functionality, volume of repair tissue, and augment Type II collagen content, aggrecan content is less than ideal. Therefore, methods to enhance key matrix components such as aggrecan after microfracture may additionally improve repair tissue observed after the procedure.

1 May 2007 in The American Journal of Pathology
Verified
Journal Article
Closed access
BDBrian M. Dufty
Brian M. Dufty
LWLisa Warner
Lisa Warner
SHSheng Tao Hou
Sheng Tao Hou
SJSusan X. Jiang
Susan X. Jiang
TGTeresa Gomez-Isla
Teresa Gomez-Isla
TRTroy T. Rohn
Troy T. Rohn

15 May 2018 in Cancers
Verified
Journal Article
Open access
PDF file
JRJake Robertson
Jake Robertson
CJCheryl L. Jorcyk
Cheryl L. Jorcyk
Julia OxfordJulia Oxford
Julia Oxford
DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the first description of DICER1 syndrome, case reports have documented novel germline mutations of the DICER1 gene in patients with cancers as well as second site mutations that alter the function of the Dicer protein expressed. Here, we present a review of mutations in the DICER1 gene, the respective protein sequence changes, and clinical manifestations of DICER1 syndrome. Directions for future research are discussed.

1 September 2008 in Protein Science
Verified
Journal Article
Closed access
PDF file
TTTakumi Takata
Takumi Takata
Julia OxfordJulia Oxford
Julia Oxford
BDBorries Demeler
Borries Demeler
KLKirsten J Lampi
Kirsten J Lampi

Verified
Journal Article
Open access
PDF file
AHAlexandria Nicole Hughes
Alexandria Nicole Hughes
AOAlexandra Oxford
Alexandra Oxford
KTKen Tawara
Ken Tawara
CJCheryl L. Jorcyk
Cheryl L. Jorcyk
Julia OxfordJulia Oxford
Julia Oxford
Chondrocytes of the growth plate undergo apoptosis during the process of endochondral ossification, as well as during the progression of osteoarthritis. Although the regulation of this process is not completely understood, alterations in the precisely orchestrated programmed cell death during development can have catastrophic results, as exemplified by several chondrodystrophies which are frequently accompanied by early onset osteoarthritis. Understanding the mechanisms that underlie chondrocyte apoptosis during endochondral ossification in the growth plate has the potential to impact the development of therapeutic applications for chondrodystrophies and associated early onset osteoarthritis. In recent years, several chondrodysplasias and collagenopathies have been recognized as protein-folding diseases that lead to endoplasmic reticulum stress, endoplasmic reticulum associated degradation, and the unfolded protein response. Under conditions of prolonged endoplasmic reticulum stress in which the protein folding load outweighs the folding capacity of the endoplasmic reticulum, cellular dysfunction and death often occur. However, unfolded protein response (UPR) signaling is also required for the normal maturation of chondrocytes and osteoblasts. Understanding how UPR signaling may contribute to cartilage pathophysiology is an essential step toward therapeutic modulation of skeletal disorders that lead to osteoarthritis.